Tracon Pharmaceuticals Inc., of San Diego, appointed Charles Theuer president and CEO...Tranzyme Pharma, of Research Triangle Park, N.C., appointed Eric Nelson vice president of business development and licensing...Vical Inc., of San Diego, promoted Robin Jackman to senior vice president of business operations

Tracon Pharmaceuticals Inc., of San Diego, appointed Charles Theuer president and CEO...Tranzyme Pharma, of Research Triangle Park, N.C., appointed Eric Nelson vice president of business development and licensing...Vical Inc., of San Diego, promoted Robin Jackman to senior vice president of business operations

Altus Pharmaceuticals Inc., of Cambridge, Mass., appointed John Sorvillo vice president of business development

and Phil Skolnick executive vice president and chief scientific officer...Iomai Corp., of Gaithersburg, Md., appointed Thomas Vernon and Weller Meyer to its board

Access Pharmaceuticals Inc., of Dallas, appointed Jeffrey Davis chairman, and Phillip Wise vice president business development and strategy

and Michael Palfreyman vice president, program management and drug development...iCo Therapeutics, of Vancouver, British Columbia, appointed Richard Barker and William Jarosz to its board, and Philip Rosenfeld to its strategic advisory team

Synta Pharmaceuticals Corp., of Lexington, Mass., appointed Martin Williams vice president of business and commercial development and chief business officer...and Suresh Babu vice president of drug product development

Celldex Therapeutics, of Phillipsburg, N.J., appointed Ronald Newbold vice president of business development, and Robert Forbes Burns CEO...and David Schenkein vice president, clinical hematology and oncology...and William Kelly vice president, investor relations and corporate communications

and Robert Quinn for CIT business and science applications...Genta Inc., of Berkeley Heights, N.J., appointed Per Lindell vice president of business development, and Lloyd Sanders vice president of sales and marketing

Affymax Inc., of Palo Alto, Calif., appointed Paul Cleveland chief financial officer and executive vice president of corporate development, and Christopher Damman vice president of business development

Lentigen Corp., of Baltimore, appointed Boro Dropulic CEO, Yung Nien Chang vice president of vector development, Gregory Feulner vice president of business development and John Woolford director of business planning...NPS Pharmaceuticals, of Salt Lake City, appointed Anthony Coles president and chief operating officer...Pharmos Corp., of Iselin, N.J., appointed Alan Rubino president and chief operating officer

Biolex Therapeutics, of Pittsboro, N.C., appointed Glen Williams senior vice president of operations, John Elliott Humphries vice president of development and Dee Parson Grange vice president of business development

Genizon BioSciences, of Montreal, appointed Claude Lambert vice president and chief financial officer, and Renno Schuurmans vice president of business development, Europe

Acorda Therapeutics Inc., of Hawthorne, N.Y., appointed Gerard Cignarella vice president of business development, and Herbert Henney vice president of medical affairs...ChemGenex Pharmaceuticals Ltd., of Melbourne, Australia, appointed Patrick Burns and Peter Bradfield to its board...Gemin X Biotechnologies Inc., of Montreal, appointed Timothy Barberich and Wayne Roe to its board

Haemonetics Corp., of Braintree, Mass., appointed Richard Meelia and Ronald Merriman to its board...Intrac Inc., of New York, and its subsidiary Innovative Drug Delivery Systems, appointed William Peters to its board...Magellan Biosciences, of Chelmsford, Mass., appointed Darren Braccia vice president of business development

Novacea Inc., of South San Francisco, appointed Fong Wang Clow senior vice president of development, Charles Democko vice president of regulatory affairs, and promoted Paul Westberg to vice president of business development

Eximias Pharmaceutical Corp., of Berwyn, Pa., appointed Jeff Randall chief financial officer, Gary Floyd vice president of operations, and John Bennett vice president of business development

Imagenetix Inc., of San Diego, formed a scientific and medical advisory board to include Jonathan Adachi, Dan Gallaher and Robert Beeten...Inyx Inc., of New York, appointed John Hamerski vice president and chief financial officer, and Josette Wys vice president business development

Topigen Pharmaceuticals Inc., of Montreal, appointed Gary Lessing and Michael Atkin to its board...Trubion Pharmaceuticals Inc., of Seattle, added Leander Lauffer as senior vice president of business development and corporate strategy